These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

546 related items for PubMed ID: 20379845

  • 1. Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.
    Mostert B, Kraan J, Bolt-de Vries J, van der Spoel P, Sieuwerts AM, Schutte M, Timmermans AM, Foekens R, Martens JW, Gratama JW, Foekens JA, Sleijfer S.
    Breast Cancer Res Treat; 2011 May; 127(1):33-41. PubMed ID: 20379845
    [Abstract] [Full Text] [Related]

  • 2. CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes.
    Mostert B, Kraan J, Sieuwerts AM, van der Spoel P, Bolt-de Vries J, Prager-van der Smissen WJ, Smid M, Timmermans AM, Martens JW, Gratama JW, Foekens JA, Sleijfer S.
    Cancer Lett; 2012 Jun 01; 319(1):49-55. PubMed ID: 22202642
    [Abstract] [Full Text] [Related]

  • 3. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
    Schneck H, Gierke B, Uppenkamp F, Behrens B, Niederacher D, Stoecklein NH, Templin MF, Pawlak M, Fehm T, Neubauer H, Disseminated Cancer Cell Network (DCC Net) Duesseldorf.
    PLoS One; 2015 Jun 01; 10(12):e0144535. PubMed ID: 26695635
    [Abstract] [Full Text] [Related]

  • 4. Multicolor detection of rare tumor cells in blood using a novel flow cytometry-based system.
    Watanabe M, Uehara Y, Yamashita N, Fujimura Y, Nishio K, Sawada T, Takeda K, Koizumi F, Koh Y.
    Cytometry A; 2014 Mar 01; 85(3):206-13. PubMed ID: 24327318
    [Abstract] [Full Text] [Related]

  • 5. A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients.
    Kim SJ, Masago A, Tamaki Y, Akazawa K, Tsukamoto F, Sato J, Ozawa T, Tsujino Y, Noguchi S.
    Breast Cancer Res Treat; 2011 Aug 01; 128(3):765-73. PubMed ID: 21630023
    [Abstract] [Full Text] [Related]

  • 6. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].
    Cai QQ, Huang HQ, Lin TX, Jiang WQ.
    Ai Zheng; 2005 Jul 01; 24(7):837-41. PubMed ID: 16004811
    [Abstract] [Full Text] [Related]

  • 7. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.
    Königsberg R, Obermayr E, Bises G, Pfeiler G, Gneist M, Wrba F, de Santis M, Zeillinger R, Hudec M, Dittrich C.
    Acta Oncol; 2011 Jun 01; 50(5):700-10. PubMed ID: 21261508
    [Abstract] [Full Text] [Related]

  • 8. Changes in keratin expression during metastatic progression of breast cancer: impact on the detection of circulating tumor cells.
    Joosse SA, Hannemann J, Spötter J, Bauche A, Andreas A, Müller V, Pantel K.
    Clin Cancer Res; 2012 Feb 15; 18(4):993-1003. PubMed ID: 22228641
    [Abstract] [Full Text] [Related]

  • 9. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.
    Deng G, Herrler M, Burgess D, Manna E, Krag D, Burke JF.
    Breast Cancer Res; 2008 Feb 15; 10(4):R69. PubMed ID: 18687126
    [Abstract] [Full Text] [Related]

  • 10. mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.
    Sieuwerts AM, Mostert B, Bolt-de Vries J, Peeters D, de Jongh FE, Stouthard JM, Dirix LY, van Dam PA, Van Galen A, de Weerd V, Kraan J, van der Spoel P, Ramírez-Moreno R, van Deurzen CH, Smid M, Yu JX, Jiang J, Wang Y, Gratama JW, Sleijfer S, Foekens JA, Martens JW.
    Clin Cancer Res; 2011 Jun 01; 17(11):3600-18. PubMed ID: 21505063
    [Abstract] [Full Text] [Related]

  • 11. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
    Adams DL, Stefansson S, Haudenschild C, Martin SS, Charpentier M, Chumsri S, Cristofanilli M, Tang CM, Alpaugh RK.
    Cytometry A; 2015 Feb 01; 87(2):137-44. PubMed ID: 25515318
    [Abstract] [Full Text] [Related]

  • 12. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.
    Pinzani P, Salvadori B, Simi L, Bianchi S, Distante V, Cataliotti L, Pazzagli M, Orlando C.
    Hum Pathol; 2006 Jun 01; 37(6):711-8. PubMed ID: 16733212
    [Abstract] [Full Text] [Related]

  • 13. Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy.
    Onstenk W, Kraan J, Mostert B, Timmermans MM, Charehbili A, Smit VT, Kroep JR, Nortier JW, van de Ven S, Heijns JB, Kessels LW, van Laarhoven HW, Bos MM, van de Velde CJ, Gratama JW, Sieuwerts AM, Martens JW, Foekens JA, Sleijfer S.
    Mol Cancer Ther; 2015 Mar 01; 14(3):821-7. PubMed ID: 25552367
    [Abstract] [Full Text] [Related]

  • 14. Global gene expression profiling of circulating tumor cells.
    Smirnov DA, Zweitzig DR, Foulk BW, Miller MC, Doyle GV, Pienta KJ, Meropol NJ, Weiner LM, Cohen SJ, Moreno JG, Connelly MC, Terstappen LW, O'Hara SM.
    Cancer Res; 2005 Jun 15; 65(12):4993-7. PubMed ID: 15958538
    [Abstract] [Full Text] [Related]

  • 15. EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low.
    Ring A, Mineyev N, Zhu W, Park E, Lomas C, Punj V, Yu M, Barrak D, Forte V, Porras T, Tripathy D, Lang JE.
    Oncotarget; 2015 Dec 29; 6(42):44623-34. PubMed ID: 26556851
    [Abstract] [Full Text] [Related]

  • 16. Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients.
    Pestrin M, Bessi S, Galardi F, Truglia M, Biggeri A, Biagioni C, Cappadona S, Biganzoli L, Giannini A, Di Leo A.
    Breast Cancer Res Treat; 2009 Dec 29; 118(3):523-30. PubMed ID: 19597704
    [Abstract] [Full Text] [Related]

  • 17. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
    Hou JM, Krebs MG, Lancashire L, Sloane R, Backen A, Swain RK, Priest LJ, Greystoke A, Zhou C, Morris K, Ward T, Blackhall FH, Dive C.
    J Clin Oncol; 2012 Feb 10; 30(5):525-32. PubMed ID: 22253462
    [Abstract] [Full Text] [Related]

  • 18. Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients.
    Tokudome N, Ito Y, Takahashi S, Kobayashi K, Taira S, Tsutsumi C, Oto M, Oba M, Inoue K, Kuwayama A, Masumura K, Nakayama Y, Watanabe C, Hatake K.
    Breast Cancer; 2011 Jul 10; 18(3):195-202. PubMed ID: 21465230
    [Abstract] [Full Text] [Related]

  • 19. Development of a molecular multimarker assay for the analysis of circulating tumor cells in adenocarcinoma patients.
    de Albuquerque A, Kubisch I, Ernst D, Breier G, Stamminger G, Fersis N, Stölzel U, Boese-Landgraf J, Eichler A, Kaul S.
    Clin Lab; 2012 Jul 10; 58(5-6):373-84. PubMed ID: 22783565
    [Abstract] [Full Text] [Related]

  • 20. Molecular signature detection of circulating tumor cells using a panel of selected genes.
    Gervasoni A, Monasterio Muñoz RM, Wengler GS, Rizzi A, Zaniboni A, Parolini O.
    Cancer Lett; 2008 May 18; 263(2):267-79. PubMed ID: 18262345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.